@prefix bibo: <http://purl.org/ontology/bibo/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-Eawag_Additional_Specs-ET405201 a mbo:MassSpectrum ;
    dcterms:creator "B. Clerc, R. Gulde, B. Lauper [com],  C. McArdell, Department of Environmental Chemistry, Eawag" ;
    dcterms:date "2020-12-17"^^xsd:date ;
    dcterms:identifier "MSBNK-Eawag_Additional_Specs-ET405201" ;
    dcterms:license <https://creativecommons.org/licenses/by-sa/4.0/> ;
    dcterms:references [ a bibo:Article ;
            rdfs:label "Gulde et al. 2020, Formation of transformation products during ozonation of secondary wastewater effluent and their fate in post-treatment: From laboratory- to full-scale, Water Research" ] ;
    dcterms:rights "Copyright (C) Eawag 2020 under CC BY-SA" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "Q Exactive Plus Orbitrap Thermo Scientific" ;
            mbo:collision_energy "15 % (nominal)" ;
            mbo:column_name "C18 Atlantis T3 5 um, 3x150 mm, Waters" ;
            mbo:flow_gradient "260/40 at 0 min, 260/40 at 5 min, 15/285 at 20 min, 15/285 at 29 min, 260/40 at 29.5 min, 260/40 at 35 min" ;
            mbo:flow_rate "300 uL/min" ;
            mbo:fragmentation_mode "HCD" ;
            mbo:instrument_type "LC-ESI-QFT" ;
            mbo:ion_mode "NEGATIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "17500" ;
            mbo:retention_time "17.653 min" ;
            mbo:solvent "A water with 0.1% formic acid",
                "B MeOH with 0.1% formic acid" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "CLI_n_453.1466_17.7",
                "Clindamycin -H2 +O2",
                "N-(2-chloro-1-(3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide -H2 +O2" ;
            mbo:ch_compound_class "identified ozonation transformation product" ;
            mbo:ch_exact_mass 4.541541e+02 ;
            schema:inChI "N/A" ;
            schema:molecularFormula "C18H31ClN2O7S" ;
            schema:name "CLI_n_453.1466_17.7",
                "Clindamycin -H2 +O2",
                "N-(2-chloro-1-(3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide -H2 +O2" ;
            schema:smiles "N/A" ] ;
    mbo:has_peak [ mbo:intensity 5.4915e+03 ;
            mbo:mz 3.910632e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 743 ],
        [ mbo:intensity 7.3859e+03 ;
            mbo:mz 4.53148e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 999 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 9.10038e+01 ;
            mbo:precursor_mz 4.531468e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 2 ;
    mbo:pk_splash "splash10-0udl-0006900000-3d793463373c390a822e" ;
    rdfs:comment "UCHEM_ID 4052" ;
    skos:definition "CLI_n_453.1466_17.7; LC-ESI-QFT; MS2; CE: 15%; R=17500; [M-H]-" .

